Concerns Rise Over Unregulated Use of Weight-Loss Drug Mounjaro in India
India's weight-loss drug market, particularly for the injectable Mounjaro (Tirzepatide), is rapidly growing but faces challenges. While effective for severe obesity under specialist supervision, Mounjaro is often sold without prescriptions and prescribed by unauthorized practitioners, raising health concerns. Patients like Saloni Khera have benefited under medical guidance, losing significant weight. Authorities restrict prescriptions to certain specialists to ensure safety, but widespread misuse highlights risks amid India's increasing demand for weight-loss solutions.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is negative (33/100). Lens Score 62/100.
Outlets measured: scrollin, scrollin. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (28–38/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
scrollin broke this story on 7 Aug, 01:07 am. Other outlets followed.
- 1